Galderma Laboratories, L.P. Company Profile

18:59 EST 23rd November 2014 | BioPortfolio

Galderma, created in 1981 as a joint venture between Nestle and L'Oreal, is a fully-integrated specialty pharmaceutical company dedicated exclusively to the field of dermatology. The Company has a presence in 65 countries with over 1,000 sales representatives and is committed to improving the health of skin with an extensive line of products across the world that treat a range of dermatological conditions including: acne, rosacea, fungal nail infections, psoriasis & steroid-responsive dermatoses, pigmentary disorders, medical solutions for skin senescence and skin cancers. With a research and development center in Sophia Antipolis, France, Galderma has one of the largest R&D facilities dedicated exclusively to dermatology. Leading U.S. brands include Epiduo® Gel, Differin® Gel, 0.3%, MetroGel® 1%, Oracea®, Cetaphil® Cleansers and Moisturizers, Tri-Luma® Cream, and Vectical® Ointment.


News Articles [399 Associated News Articles listed on BioPortfolio]

Galderma earns wrath of PMCPA in unprecedented case

Galderma has sensationally pulled out of the UK’s good conduct pact after the watchdog overseeing the ABPI Code found ‘extremely concerning’ breaches were made by the firm.  The PMCPA, whic...

Valeant sells its dermatology products for $1.4 billion

Valeant Pharmaceuticals International has entered into an agreement with Nestle to sell all rights to Restylane, Perlane, Emervel, Sculptra, and Dysport owned or held by Valeant for $1.4 billion in ca...

Ipsen, Galderma Expand Neurotoxin Partnership

Ipsen, a global specialty-driven pharmaceutical company, and Galderma, a global healthcare company focused on dermatology and skin health, announced that they have significantly expa

Galderma finalizes major expansion in aesthetic and corrective dermatology in US, Canada

Galderma announced that it has gained full rights to distribute Restylane, Perlane, Emervel, Sculptra and Dysport from Valeant Pharmaceuticals International.

Ipsen and Galderma expand neurotoxins partnership

French drugmaker Ipsen and global dermatology and skin health company Galderma have expanded the scope of their neurotoxin partnership.

FDA Grants Orphan Drug Designation for Galderma’s Trifarotene Molecule in the Treatment of Congenital Ichthyosis

Galderma announced that the FDA granted Orphan Drug Designation status for the company’s trifarotene molecule for the treatment of congenital ichthyosis. Based on this decision, Galderma plans to im...

Nestlé-Tochter Galderma baut Kooperation mit Ipsen bei Neurotoxinen aus

Zürich (awp) - Galderma, die vor kurzem vollständig von Nestlé übernommen wurde, und der französische Pharmakonzern Ipsen haben eine Vertiefung ihrer bereits bestehenden Zusammenarbeit im Bereich...

Ipsen, Galderma become exclusive partners for development and marketing of neurotoxins

Ipsen, a global specialty-driven pharmaceutical company, and Galderma, a global healthcare company focused on dermatology and skin health, has announced that they have significantly expanded the scope...

Drugs and Medications [432 Associated Drugs and Medications listed on BioPortfolio]

Cetaphil [Galderma Laboratories, L.P.]

Cetaphil Daily Facial Moisturizer

Cetaphil dermacontrol spf 30 [Galderma Laboratories, L.P.]

Drug Facts

Metrocream [Galderma Laboratories, L.P.]

MetroCream®(metronidazole topical cream) Rx Only FOR TOPICAL USE ONLY(NOT FOR OPHTHALMIC USE)

Differin [Galderma Laboratories, L.P.]

DIFFERIN (adapalene gel)Gel, 0.1%Rx Only

Rosanil [Galderma Laboratories, L.P.]

ROSANIL® Cleanser(sodium sulfacetamide 10% and sulfur 5%)Rx only

PubMed Articles [175 Associated PubMed Articles listed on BioPortfolio]

Completeness and Timeliness of Electronic vs. Conventional Laboratory Reporting for Communicable Disease Surveillance-Oklahoma, 2011.

The Health Information Technology for Economic and Clinical Health (HITECH) Act encourages the meaningful use of certified electronic health record technology. A HITECH-compliant core component is nat...

CardioPluse. Radiation exposure to personnel in cardiac catheterization laboratories: an English summary of a published manuscript where radiation exposure in the cath lab was measured by the lead author Dr Heiner von Bötticher catheterization laboratories.

Impact of Changes in Clostridium difficile Testing Practices on Stool Rejection Policies and C. difficile Positivity Rates across Multiple Laboratories in the United States.

We describe the adoption of nucleic acid amplification tests (NAAT) for Clostridium difficile diagnosis and their impact on stool rejection policies and C. difficile positivity rates. Of the laborator...

Toward Standardization of Hair Cortisol Measurement; Results of the First International Inter-laboratory Round Robin.

The importance of hair cortisol as a long-term, retrospective measure of systemic cortisol exposure is being increasingly recognized, and over recent years the field of hair cortisol analysis has seen...

Comparison of Two Multifocal Intraocular Lens Designs That Differ Only in Near Add.

To evaluate monocular functional outcomes after the implantation of the AcrySof ReSTOR SN6AD2 intraocular lens (IOL) (+2.5 diopters [D] near add) (Alcon Laboratories, Inc., Fort Worth, TX) and the Acr...

Clinical Trials [169 Associated Clinical Trials listed on BioPortfolio]

Randomized, Double-blind, Multiple-site, Placebo-controlled, Parallel-design Study in Patients With Moderate to Severe Facial Erythema Associated With Rosacea

A Randomized, Double-Blind, Multiple-Site, Placebo-Controlled, Parallel-Design Study to Evaluate the Safety and Therapeutic Equivalence of Brimonidine Topical Gel, 0.33% (Watson Laboratori...

Study Comparing 0.3% Adapalene Topical Gel to Differin® 0.3% Adapalene Topical Gel

Marketed by Galderma Laboratories, L.P., Differin® (adapalene 0.3% topical gel) is a safe and effective topical therapy used for the treatment of acne vulgaris. Actavis Mid-Atlantic LLC h...

Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fed Condition

The objective of this study is to determine the relative bioavailability of one 15 mg Meloxicam tablet (Dr. Reddy. Laboratories Ltd.,Generics) versus one 15 mg Mobic (meloxicam) Tablet (Bo...

Bioequivalence Study of Dr.Reddy's Laboratories Limited Finasteride Tablets 1 mg Under Fed Condition

The objective of this study was to compare the single-dose relative bioavailability of Dr. Reddy's Laboratories, Ltd. and Merck & Co. (Propecia®) 1 mg finasteride tablets under fed condi...

Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fasting Condition

The objective of this study is to determine the relative bioavailability of one 15 mg Meloxicam tablet (Dr. Reddy. Laboratories Ltd.,Generics) versus one 15 mg Mobic (meloxicam) Tablet (Bo...

Companies [890 Associated Companies listed on BioPortfolio]

Galderma Pharma S.A.

Galderma KK, the fully-owned Japanese arm of Galderma, was established in 1996. It has been marketing the topical anti-fungal product Pekiron(R) Cream 0.5% (Loceryl(R)) under a licensing agreement...

Galderma Laboratories

Galderma’s ambition is to be recognized as the most competent and successful innovation-based company focused exclusively on meeting the needs of dermatology patients and phy...

Galderma, MTV

Galderma is one of the world's leading pharmaceutical companies, focusing exclusively on the research, development and marketing of dermatological products. Its expertise spans a broad spectrum of...

Galderma Laboratories, L.P.

Galderma, created in 1981 as a joint venture between Nestle and L'Oreal, is a fully-integrated specialty pharmaceutical company dedicated exclusively to the field of dermatology. The Company has a pre...

GALDERMA LABORATORIES L.P.

Since the creation of Galderma in 1981 as a joint venture between Nestlé and L'Oréal, all of our resources have been channelled in one direction: to provide innovative therapeutic solutions that mee...

More Information about "Galderma Laboratories, L.P." on BioPortfolio

We have published hundreds of Galderma Laboratories, L.P. news stories on BioPortfolio along with dozens of Galderma Laboratories, L.P. Clinical Trials and PubMed Articles about Galderma Laboratories, L.P. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Galderma Laboratories, L.P. Companies in our database. You can also find out about relevant Galderma Laboratories, L.P. Drugs and Medications on this site too.

Search BioPortfolio:
Loading
Advertisement

Relevant Topics

Rheumatology
Latest News Clinical Trials Research Drugs Reports Corporate
Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Dictionary). It is an active area of medical research, because of the d...

The Top 100 Pharmaceutical Companies
Latest News Clinical Trials Research Drugs Reports Corporate
Top 100 Pharmaceutical Companies 2012 (SCRIP 100 - http://www.scrip100.com/scrip100.html) Rank (2011 in Brackets) Company SEARCH FOR COMPANY IN BIOPORTFOLIO'S BIOCORPORATE DATABASE 2012 pharma sales...

Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record